Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 7, 2015 - Issue
Submit an article Journal homepage
84
Views
20
CrossRef citations to date
0
Altmetric
Original Research

Cost-effectiveness of ranibizumab versus aflibercept in the treatment of visual impairment due to diabetic macular edema: a UK healthcare perspective

Stephane A Régnier1 Novartis Pharma AG, Basel, SwitzerlandCorrespondence[email protected]
,
William Malcolm2 Novartis Pharmaceuticals UK Ltd, Frimley Business Park, UK
,
Jennifer Haig3 Optum, Burlington, ON, Canada
&
Weiguang Xue4 Optum, Uxbridge, UK
Pages 235-247 | Published online: 06 May 2015

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.